Progression Free Survival Increases regardless of PDL-1 Expressions By Steve|2019-07-17T04:06:29+00:00October 22nd, 2018|Archived| Read More 0
Cholangiocarcinoma – Keytruda as a first line treatment option ? By Steve|2018-09-28T06:36:48+00:00September 26th, 2018|All, IMMUNOTHERAPY| Read More 0
Simplifying Immunotherapy terminology By Steve|2019-07-18T06:37:56+00:00September 15th, 2018|Archived| Read More 1
Vyriad Expands Phase 1 Trial to Test Voyager-V1 By Steve|2018-07-28T06:11:12+00:00July 28th, 2018|All, IMMUNOTHERAPY, Media, TRIALS| Read More 0
Can Bile Duct Cancer’s follow the Melanoma lead By Steve|2018-01-11T07:54:34+00:00January 11th, 2018|All, IMMUNOTHERAPY| Read More 0
